Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives (THPBs) as proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators for the treatment of hyperlipidemiaChenglin Wu, Hong Liu|Acta Pharmaceutica Sinica B|2019Cited by 26